Specialty Pharmacy Market Ripe For Private Equity Buyers

Law360, New York (October 1, 2015, 5:25 PM EDT) -- The specialty pharmacy market is particularly ripe for opportunity. We've seen increased merger and acquisition activity in this health care sector, with consistently high valuations, as a variety of different candidates look for acquisition opportunities, including large retail pharmacy chains and big-box retailers looking to expand their holdings. Private equity investors have also been active in the market, while a number of other private equity sellers have been the beneficiaries of this robust market, as they sell their specialty pharmacy portfolio companies at attractive valuations....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!